Yoninah Segal

774 total citations
11 papers, 619 citations indexed

About

Yoninah Segal is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Yoninah Segal has authored 11 papers receiving a total of 619 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 9 papers in Virology and 6 papers in Emergency Medicine. Recurrent topics in Yoninah Segal's work include HIV/AIDS drug development and treatment (11 papers), HIV Research and Treatment (9 papers) and HIV-related health complications and treatments (6 papers). Yoninah Segal is often cited by papers focused on HIV/AIDS drug development and treatment (11 papers), HIV Research and Treatment (9 papers) and HIV-related health complications and treatments (6 papers). Yoninah Segal collaborates with scholars based in United States, Netherlands and Cyprus. Yoninah Segal's co-authors include Susan L. Rosenkranz, Judith A. Aberg, John G. Gerber, Beverly Alston, Carl J. Fichtenbaum, Francesca Aweeka, Terrence F. Blaschke, Fang Fang, Bradley W. Kosel and Susan W. Brobst and has published in prestigious journals such as Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy and Clinical Pharmacology & Therapeutics.

In The Last Decade

Yoninah Segal

11 papers receiving 595 citations

Peers

Countries citing papers authored by Yoninah Segal

Since Specialization

Citations

This map shows the geographic impact of Yoninah Segal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoninah Segal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoninah Segal more than expected).

Fields of papers citing papers by Yoninah Segal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoninah Segal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoninah Segal. The network helps show where Yoninah Segal may publish in the future.

Co-authorship network of co-authors of Yoninah Segal

This figure shows the co-authorship network connecting the top 25 collaborators of Yoninah Segal. A scholar is included among the top collaborators of Yoninah Segal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoninah Segal. Yoninah Segal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	The impact of sex and contraceptive therapy on the plasma and intracellular pharmacokinetics of zidovudine 2006 ·AIDS ·Francesca Aweeka, Susan L. Rosenkranz, Yoninah Segal, Robert W. Coombs, Arlene Bardeguez, (unknown), Patricia Lizak, Judith A. Aberg, D. Heather Watts	30
2	Pharmacokinetic interaction between nelfinavir and pravastatin in HIV-seronegative volunteers: ACTG Study A5108 2006 ·AIDS ·Judith A. Aberg, Susan L. Rosenkranz, Carl J. Fichtenbaum, Beverly Alston, Susan W. Brobst, Yoninah Segal, John G. Gerber	32
3	Effect of Efavirenz on the Pharmacokinetics of Simvastatin, Atorvastatin, and Pravastatin 2005 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·John G. Gerber, Susan L. Rosenkranz, Carl J. Fichtenbaum, José M. Vega, Amy Y. Yang, Beverly Alston, Susan W. Brobst, Yoninah Segal, Judith A. Aberg	136
4	Amprenavir and Efavirenz Pharmacokinetics before and after the Addition of Nelfinavir, Indinavir, Ritonavir, or Saquinavir in Seronegative Individuals 2005 ·Antimicrobial Agents and Chemotherapy ·Gene D. Morse, Susan L. Rosenkranz, Michael F. Para, Yoninah Segal, Robin DiFrancesco, Elizabeth L. Adams, Barbara Brizz, Kevin E. Yarasheski, Richard C. Reichman	13
5	Activity, Safety, and Immunological Effects of Hydroxyurea Added to Didanosine in Antiretroviral-Naive and Experienced HIV Type 1-Infected Subjects: A Randomized, Placebo-Controlled Trial, ACTG 307 2004 ·AIDS Research and Human Retroviruses ·Ian Frank, Ronald J. Bosch, Susan A. Fiscus, Fred Valentine, Charles Flexner, Yoninah Segal, Ping Ruan, Roy M. Gulick, Kenneth W. Wood, (unknown), Lawrence Fox, Thomas Nevin, M. L. Stevens, Joseph J. Eron	21
6	The Clinical Pharmacokinetics of Pyrazinamide in HIV‐Infected Persons with Tuberculosis 2004 ·Clinical Infectious Diseases ·David C. Perlman, Yoninah Segal, Susan L. Rosenkranz, Petrie M. Rainey, Charles A. Peloquin, Rory P. Remmel, Keith Chirgwin, Nadim Salomon, Richard Hafner, (unknown)	11
7	Activity, Safety, and Immunological Effects of Hydroxyurea Added to Didanosine in Antiretroviral-Naive and Experienced HIV Type 1-Infected Subjects: A Randomized, Placebo-Controlled Trial, ACTG 307 2004 ·AIDS Research and Human Retroviruses ·Ian Frank, Ronald J. Bosch, Susan A. Fiscus, Fred Valentine, Charles Flexner, Yoninah Segal, (unknown), Roy M. Gulick, Kenneth Wood, (unknown), Lawrence K. Fox, (unknown), M. L. Stevens, Joseph J. Eron, (unknown)	2
8	Effect of simultaneous versus staggered dosing on pharmacokinetic interactions of protease inhibitors 2003 ·Clinical Pharmacology & Therapeutics ·Carla Washington, Charles Flexner, Lewis B. Sheiner, Susan L. Rosenkranz, Yoninah Segal, Judith A. Aberg, Terrence F. Blaschke	16
9	Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG Study A5047 2002 ·AIDS ·Carl J. Fichtenbaum, John G. Gerber, Susan L. Rosenkranz, Yoninah Segal, Judith A. Aberg, Terrence F. Blaschke, Beverly Alston, Fang Fang, Bradley W. Kosel, Francesca Aweeka	272
10	Effect of Ritonavir/Saquinavir on Stereoselective Pharmacokinetics of Methadone: Results of AIDS Clinical Trials Group (ACTG) 401 2001 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·John G. Gerber, Susan L. Rosenkranz, Yoninah Segal, Judith A. Aberg, Ronald D’Amico, Donna Mildvan, Roy M. Gulick, Valery Hughes, Charles Flexner, Francesca Aweeka, Ann Hsu, J. Gál	63
11	Effect of Ritonavir/Saquinavir on Stereoselective Pharmacokinetics of Methadone: Results of AIDS Clinical Trials Group (ACTG) 401 2001 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·John G. Gerber, Susan L. Rosenkranz, Yoninah Segal, Judith A. Aberg, Ronald D’Amico, Donna Mildvan, Roy M. Gulick, Valery Hughes, Charles Flexner, Francesca Aweeka, Ann Hsu, J. Gál	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact